Terms: = Bone cancer AND TNFRSF14, Q92956, 8764, ENSG00000157873, TR2, ATAR, LIGHTR, HVEM, HVEA
19 results:
1. Single-cell RNA sequencing reveals XBP1-SLC38A2 axis as a metabolic regulator in cytotoxic T lymphocytes in multiple myeloma.
Wan Y; Chen M; Li X; Han X; Zhong L; Xiao F; Liu J; Xiang J; Jiang J; Chen X; Liu J; Li H; Li B; Huang H; Hou J
Cancer Lett; 2023 May; 562():216171. PubMed ID: 37054944
[TBL] [Abstract] [Full Text] [Related]
2. Follicle Center Lymphoma (FCL) of the Lower Female Genital Tract (LFGT): A Novel Variant of Primary Cutaneous Follicle Center Lymphoma (PCFCL).
Saksena A; Jain A; Pack SD; Kim J; Lee I; Tyagi M; Xi L; Pittaluga S; Raffeld M; Jaffe ES
Am J Surg Pathol; 2023 Mar; 47(3):409-419. PubMed ID: 36461146
[TBL] [Abstract] [Full Text] [Related]
3. Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer.
Nalawade SA; Shafer P; Bajgain P; McKenna MK; Ali A; Kelly L; Joubert J; Gottschalk S; Watanabe N; Leen A; Parihar R; Vera Valdes JF; Hoyos V
J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34815355
[TBL] [Abstract] [Full Text] [Related]
4. Frequent mutated B2M, EZH2, IRF8, and tnfrsf14 in primary bone diffuse large B-cell lymphoma reflect a GCB phenotype.
de Groen RAL; van Eijk R; Böhringer S; van Wezel T; Raghoo R; Ruano D; Jansen PM; Briaire-de Bruijn I; de Groot FA; Kleiverda K; Te Boome L; Terpstra V; Levenga H; Nicolae A; Posthuma EFM; Focke-Snieders I; Hardi L; den Hartog WCE; Bohmer LH; Hogendoorn PCW; van den Berg A; Diepstra A; Nijland M; Lugtenburg PJ; Kersten MJ; Pals ST; Veelken H; Bovée JVMG; Cleven AHG; Vermaat JSP
Blood Adv; 2021 Oct; 5(19):3760-3775. PubMed ID: 34478526
[TBL] [Abstract] [Full Text] [Related]
5. The Tumor Microenvironment in Follicular Lymphoma: Its Pro-Malignancy Role with Therapeutic Potential.
Watanabe T
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069564
[TBL] [Abstract] [Full Text] [Related]
6. Single-Cell RNA Sequencing Reveals Tissue Compartment-Specific Plasticity of Mycosis Fungoides Tumor Cells.
Rindler K; Bauer WM; Jonak C; Wielscher M; Shaw LE; Rojahn TB; Thaler FM; Porkert S; Simonitsch-Klupp I; Weninger W; Mayerhoefer ME; Farlik M; Brunner PM
Front Immunol; 2021; 12():666935. PubMed ID: 33968070
[TBL] [Abstract] [Full Text] [Related]
7. Canine osteosarcoma checkpoint expression correlates with metastasis and T-cell infiltrate.
Cascio MJ; Whitley EM; Sahay B; Cortes-Hinojosa G; Chang LJ; Cowart J; Salute M; Sayour E; Dark M; Sandoval Z; Mitchell DA; Milner RJ
Vet Immunol Immunopathol; 2021 Feb; 232():110169. PubMed ID: 33387703
[TBL] [Abstract] [Full Text] [Related]
8. Primary superficial Ewing sarcoma: A unique entity? A case report including novel findings of ELF3 and tnfrsf14 copy number loss.
Murphy LD; Orman GM; Bridge JA; Bajaj G; Gardner JM; Douglass DP
J Cutan Pathol; 2020 Oct; 47(10):970-975. PubMed ID: 32483824
[TBL] [Abstract] [Full Text] [Related]
9. Various checkpoint molecules, and tumor-infiltrating lymphocytes in common pediatric solid tumors: Possibilities for novel immunotherapy.
Mochizuki K; Kawana S; Yamada S; Muramatsu M; Sano H; Kobayashi S; Ohara Y; Takahashi N; Hakozaki M; Yamada H; Hashimoto Y; Kikuta A
Pediatr Hematol Oncol; 2019 Feb; 36(1):17-27. PubMed ID: 30870043
[TBL] [Abstract] [Full Text] [Related]
10. tr2 and TR4 Orphan Nuclear Receptors: An Overview.
Lin SJ; Yang DR; Yang G; Lin CY; Chang HC; Li G; Chang C
Curr Top Dev Biol; 2017; 125():357-373. PubMed ID: 28527578
[TBL] [Abstract] [Full Text] [Related]
11. The prognostic utility of the transcription factor SRF in docetaxel-resistant prostate cancer: in-vitro discovery and in-vivo validation.
Lundon DJ; Boland A; Prencipe M; Hurley G; O'Neill A; Kay E; Aherne ST; Doolan P; Madden SF; Clynes M; Morrissey C; Fitzpatrick JM; Watson RW
BMC Cancer; 2017 Mar; 17(1):163. PubMed ID: 28249598
[TBL] [Abstract] [Full Text] [Related]
12. T-cell responses against CD19+ pediatric acute lymphoblastic leukemia mediated by bispecific T-cell engager (BiTE) are regulated contrarily by PD-L1 and CD80/CD86 on leukemic blasts.
Feucht J; Kayser S; Gorodezki D; Hamieh M; Döring M; Blaeschke F; Schlegel P; Bösmüller H; Quintanilla-Fend L; Ebinger M; Lang P; Handgretinger R; Feuchtinger T
Oncotarget; 2016 Nov; 7(47):76902-76919. PubMed ID: 27708227
[TBL] [Abstract] [Full Text] [Related]
13. Osteoclasts promote immune suppressive microenvironment in multiple myeloma: therapeutic implication.
An G; Acharya C; Feng X; Wen K; Zhong M; Zhang L; Munshi NC; Qiu L; Tai YT; Anderson KC
Blood; 2016 Sep; 128(12):1590-603. PubMed ID: 27418644
[TBL] [Abstract] [Full Text] [Related]
14. RNA and protein expression of herpesvirus entry mediator (hvem) is associated with molecular markers, immunity-related pathways and relapse-free survival of patients with AML.
Lichtenegger FS; Kondla I; Krempasky M; Weber AL; Herold T; Krupka C; Spiekermann K; Schneider S; Büchner T; Berdel WE; Wörmann BJ; Hiddemann W; Subklewe M
Cancer Immunol Immunother; 2015 Dec; 64(12):1505-15. PubMed ID: 26377688
[TBL] [Abstract] [Full Text] [Related]
15. LIGHT regulates the adipogenic differentiation of mesenchymal stem cells.
Liu C; Ding H; Zhu W; Jiang S; Xu J; Zou GM
J Cell Biochem; 2013 Feb; 114(2):346-53. PubMed ID: 22930663
[TBL] [Abstract] [Full Text] [Related]
16. 18F-FDG PET, combined FDG-PET/CT and MRI for evaluation of bone marrow infiltration in staging of lymphoma: a systematic review and meta-analysis.
Wu LM; Chen FY; Jiang XX; Gu HY; Yin Y; Xu JR
Eur J Radiol; 2012 Feb; 81(2):303-11. PubMed ID: 21145680
[TBL] [Abstract] [Full Text] [Related]
17. Evaluation of 1p36 markers and clinical outcome in a skull base chordoma study.
Longoni M; Orzan F; Stroppi M; Boari N; Mortini P; Riva P
Neuro Oncol; 2008 Feb; 10(1):52-60. PubMed ID: 18094369
[TBL] [Abstract] [Full Text] [Related]
18. Reduced folate carrier protein expression in osteosarcoma: implications for the prediction of tumor chemosensitivity.
Ifergan I; Meller I; Issakov J; Assaraf YG
Cancer; 2003 Nov; 98(9):1958-66. PubMed ID: 14584080
[TBL] [Abstract] [Full Text] [Related]
19. Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics.
Picado C; Fernandez-Morata JC; Juan M; Roca-Ferrer J; Fuentes M; Xaubet A; Mullol J
Am J Respir Crit Care Med; 1999 Jul; 160(1):291-6. PubMed ID: 10390414
[TBL] [Abstract] [Full Text] [Related]